311 related articles for article (PubMed ID: 26840568)
1. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
2. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Chen H; Werner S; Tao S; Zörnig I; Brenner H
Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
[TBL] [Abstract][Full Text] [Related]
3. Serum autoantibodies in the early detection of esophageal cancer: a systematic review.
Zhang H; Xia J; Wang K; Zhang J
Tumour Biol; 2015 Jan; 36(1):95-109. PubMed ID: 25433500
[TBL] [Abstract][Full Text] [Related]
4. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: serum autoantibodies in the early detection of gastric cancer.
Werner S; Chen H; Tao S; Brenner H
Int J Cancer; 2015 May; 136(10):2243-52. PubMed ID: 24615018
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
[TBL] [Abstract][Full Text] [Related]
7. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.
Bracci PM; Zhou M; Young S; Wiemels J
Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody biomarker opens a new gateway for cancer diagnosis.
Nesterova M; Johnson N; Cheadle C; Cho-Chung YS
Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies: Opportunities for Early Cancer Detection.
Macdonald IK; Parsy-Kowalska CB; Chapman CJ
Trends Cancer; 2017 Mar; 3(3):198-213. PubMed ID: 28718432
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
14. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profiles as biomarkers of breast cancer.
Tabernero MD; Lv LL; Anderson KS
Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
[TBL] [Abstract][Full Text] [Related]
16. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
[TBL] [Abstract][Full Text] [Related]
17. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
